Real-Time Intelligence from the Haematology Congress Spotlight
This case study demonstrates how a top global pharmaceutical company leveraged AI-driven analytics to decode healthcare professional (HCP) reactions to breakthrough hematology therapies across major global congresses. By transforming unstructured digital conversations from ASCO, EHA, and ICML into actionable insights, the organization gained rapid clarity on sentiment, engagement, and scientific impact—while dramatically improving efficiency and scale.
Client
Our client—a forward-thinking life sciences leader wanted actionable intel on how healthcare professionals (HCPs) were reacting to game-changing therapies like bispecifics, trispecifics, antibody-drug conjugates (ADCs), and menin inhibitors.